UK – CMOs urge trusts to continue recruiting for RECOVERY trial

The UK’s four Chief Medical Officers (CMOs) and NHS England and Improvements’ National Medical Director are urging NHS trusts across the country to continue recruiting high numbers of COVID-19 patients into the RECOVERY trial.

In a joint letter, sent to every NHS trust, they say that now there is less workforce pressure it should be the default position to offer every patient enrolment into a trial, with a target of recruiting 60% of eligible patients.

The RECOVERY trial has already shown that dexamethasone cuts deaths by one-third in patients receiving invasive mechanical ventilation and by one-fifth in patients receiving oxygen, which has “informed clinical practice worldwide and was down to your efforts in facilitating research in the NHS,” the CMOs note…